• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 94 of 100
JPMorgan Chase & Co. CEO Jamie Dimon Speaks At An Institute Of International Finance Panel
FeaturesECB peps markets and JPMorgan shareholders vote on Dimon’s pay–5 things to know today
By Laura LorenzettiMay 19, 2015
157934085
FeaturesThe pharma M&A party is still in full swing, as Endo snaps up Par
By Geoffrey SmithMay 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
TechGlaxoSmithKline plans to work with U.S. scientists to develop a cure for AIDS
By ReutersMay 11, 2015
FinanceBiopharma deals are booming this year with no end in sight
By Laura LorenzettiMay 8, 2015
FeaturesCancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
By Laura LorenzettiMay 8, 2015
FeaturesJ&J brings in ethicists to judge on requests for experimental drugs
By ReutersMay 7, 2015
Inside of a Gilead Sciences Lab
TechDrugmaker Alexion boosts its rare drug pipeline with $8.4 billion deal
By ReutersMay 6, 2015
Clashes in Baltimore over death of Freddie Gray
FeaturesBaltimore riots, Google, and Twitter earnings — 5 things to know today
By Laura LorenzettiApril 28, 2015
Ontario Closer Than Ever To Legalization Of Marijuana
LeadershipHow new blood in Washington, DC could impact the marijuana industry
By Tom Huddleston Jr.April 24, 2015
PA: Mylan Headquarters
FinanceMylan plays monkey-in-the-middle of hostile takeover battles
By Jen WiecznerApril 21, 2015
PA: Mylan Headquarters
FinanceTeva offers to buy rival Mylan for $40 billion to create generics giant
By Laura LorenzettiApril 21, 2015
Newest Innovations In Consumer Technology On Display At 2014 International CES
FeaturesEU goes after Gazprom, and Teva eyes Mylan — 5 things to know today
By Laura LorenzettiApril 21, 2015
pancreatic cancer cell
TechHow one company is using artificial intelligence to develop a cure for cancer
By Cyrus SanatiApril 16, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
FeaturesAmericans spent a record amount on medicine in 2014
By TIMEApril 14, 2015
IL: Corporations In Illinois
FinanceHospira hit with further FDA scrutiny after $17 billion Pfizer deal
By Laura LorenzettiApril 8, 2015
1...
  • 92
  • 93
  • 94
  • 95
  • 96
...100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.